Bank of New York Mellon’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-17,705
| Closed | -$3.84M | – | 4539 |
|
|
2021
Q1 | $3.84M | Sell |
17,705
-370,002
| -95% | -$69.5M | ﹤0.01% | 2569 |
|
|
2020
Q4 | $44.7M | Buy |
387,707
+9,674
| +3% | +$1.08M | 0.01% | 1114 |
|
|
2020
Q3 | $36.8M | Buy |
378,033
+5,505
| +1% | +$634K | 0.01% | 1090 |
|
|
2020
Q2 | $45.7M | Buy |
372,528
+119,421
| +47% | +$13.5M | 0.01% | 934 |
|
|
2020
Q1 | $22.2M | Buy |
253,107
+48,512
| +24% | +$5.14M | 0.01% | 1230 |
|
|
2019
Q4 | $21.4M | Buy |
204,595
+46,783
| +30% | +$5.25M | 0.01% | 1533 |
|
|
2019
Q3 | $18.2M | Buy |
157,812
+10,072
| +7% | +$1.53M | 0.01% | 1592 |
|
|
2019
Q2 | $25.5M | Buy |
147,740
+1,969
| +1% | +$341K | 0.01% | 1414 |
|
|
2019
Q1 | $24.6M | Buy |
145,771
+1,003
| +0.7% | +$149K | 0.01% | 1429 |
|
|
2018
Q4 | $14.1M | Buy |
144,768
+135,599
| +1,479% | +$17.8M | ﹤0.01% | 1704 |
|
|
2018
Q3 | $1.58M | Sell |
9,169
-3,884
| -30% | -$560K | ﹤0.01% | 2994 |
|
|
2018
Q2 | $1.82M | Buy |
13,053
+7,496
| +135% | +$1.06M | ﹤0.01% | 2904 |
|
|
2018
Q1 | $627K | Buy |
5,557
+244
| +5% | +$30.7K | ﹤0.01% | 3465 |
|
|
2017
Q4 | $701K | Buy |
+5,313
| New | +$624K | ﹤0.01% | 3443 |
|
|
2017
Q2 | – | Sell |
-233,831
| Closed | -$28.3M | – | 4372 |
|
|
2017
Q1 | $28.3M | Sell |
233,831
-221,996
| -49% | -$27.2M | 0.01% | 1340 |
|
|
2016
Q4 | $50.9M | Sell |
455,827
-305,345
| -40% | -$36.8M | 0.01% | 925 |
|
|
2016
Q3 | $101M | Sell |
761,172
-167,664
| -18% | -$16M | 0.03% | 538 |
|
|
2016
Q2 | $85.1M | Sell |
928,836
-209,444
| -18% | -$17.6M | 0.03% | 592 |
|
|
2016
Q1 | $82.1M | Buy |
1,138,280
+156,122
| +16% | +$8.57M | 0.02% | 637 |
|
|
2015
Q4 | $68.2M | Buy |
982,158
+169,218
| +21% | +$13.8M | 0.02% | 711 |
|
|
2015
Q3 | $74.3M | Buy |
812,940
+89,971
| +12% | +$10M | 0.02% | 659 |
|
|
2015
Q2 | $88.8M | Buy |
722,969
+40,446
| +6% | +$4.59M | 0.02% | 638 |
|
|
2015
Q1 | $62.2M | Buy |
682,523
+586,736
| +613% | +$47.6M | 0.02% | 795 |
|
|
2014
Q4 | $6.48M | Buy |
95,787
+86,177
| +897% | +$6.29M | ﹤0.01% | 2164 |
|
|
2014
Q3 | $777K | Buy |
+9,610
| New | +$850K | ﹤0.01% | 3435 |
|
Other funds holding GWPH
Bank of New York Mellon's GWPH Position: Q2 2021 in Review
Bank of New York Mellon sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 17,705 shares — an estimated $3.84M sold.
Bank of New York Mellon first reported a position in GWPH in Q3 2014 and held it in 25 quarters. The position peaked at $101M in Q3 2016. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Bank of New York Mellon reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Bank of New York Mellon sold 17,705 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $3.84M.
- Bank of New York Mellon first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 25 quarters.
- Bank of New York Mellon's GW Pharmaceuticals Plc American Depositary Shares position peaked at $101M in Q3 2016.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.